Submitted by Anonymous (not verified) on 24 October 2024 - 14:54
Pharmacovigilance Risk Assessment Committee (PRAC): 8 - 11 June 2026, European Medicines Agency, Amsterdam, the Netherlands, from 8 June 2026 to 11 June 2026
Source:
Pharmacovigilance Risk Assessment Committee (PRAC): 8 - 11 June 2026, European Medicines Agency, Amsterdam, the Netherlands, from 8 June 2026 to 11 June 2026